Basal linear deposit and large drusen are specific for early age-related maculopathy.
about
The potential role of amyloid beta in the pathogenesis of age-related macular degeneration.The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculasCellular and Molecular Pathology of Age-Related Macular Degeneration: Potential Role for ProteoglycansThe proteomics of drusenRecent developments in the management of dry age-related macular degenerationImpaired electroretinogram (ERG) response in apolipoprotein E-deficient miceThe Evolution of the Plateau, an Optical Coherence Tomography Signature Seen in Geographic Atrophy.Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice.CTGF is increased in basal deposits and regulates matrix production through the ERK (p42/p44mapk) MAPK and the p38 MAPK signaling pathways.Abundant lipid and protein components of drusenA short-duration dark adaptation protocol for assessment of age-related maculopathyApolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).Fundus autofluorescence and spectral-domain optical coherence tomography characteristics in a rapidly progressing form of geographic atrophy.Age-related retinopathy in NRF2-deficient mice.Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.Age-related impairment in choroidal blood flow compensation for arterial blood pressure fluctuation in pigeons.Age-related maculopathy and the impact of blue light hazard.Cigarette smoke-related hydroquinone induces filamentous actin reorganization and heat shock protein 27 phosphorylation through p38 and extracellular signal-regulated kinase 1/2 in retinal pigment epithelium: implications for age-related macular degThree gene-targeted mouse models of RNA splicing factor RP show late-onset RPE and retinal degeneration.The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids.Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.Mice that produce ApoB100 lipoproteins in the RPE do not develop drusen yet are still a valuable experimental systemAge-related macular degeneration and nutritional supplementation: a review of randomised controlled trials.High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in womenA CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degenerationChoriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degenerationAging, age-related macular degeneration, and the response-to-retention of apolipoprotein B-containing lipoproteins.Anatomic alterations in aging and age-related diseases of the eye.Decreased thickness and integrity of the macular elastic layer of Bruch's membrane correspond to the distribution of lesions associated with age-related macular degeneration.Complement activation and choriocapillaris loss in early AMD: implications for pathophysiology and therapy.The relationship between intervention in the CD40 signal pathway and choroidal neovascularizationLipids, lipoproteins, and age-related macular degenerationIncreased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice.Human chorioretinal layer thicknesses measured in macula-wide, high-resolution histologic sectionsProgress and perspectives on the role of RPE cell inflammatory responses in the development of age-related macular degeneration.Increased expression of vascular endothelial growth factor associated with accumulation of lipids in Bruch's membrane of LDL receptor knockout miceRegulation of age-related macular degeneration-like pathology by complement factor H.Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy.
P2860
Q24532130-E7E747AC-D2D9-47E2-B989-FEE3480564D8Q24602544-EBDEE14C-5229-488D-8A4A-3770386EBD85Q26738776-25CC9A88-4290-4289-B63B-F5C6F4E75AABQ26997523-6A4FB67B-FB4A-40EE-B135-56ABC3C42CDFQ28088816-E942469E-9B0B-4BF1-937C-28AB8678582AQ28588554-B3693B3F-7C96-4AD6-8521-702D6A7FC502Q30847480-00624C7B-DC19-4FDF-A45E-7042D3A014C9Q33366509-6611292A-4D6D-47D0-9D4E-9B21CDE3BDBCQ33384586-8403E2CC-BCD9-445F-892A-DB60B7CC5502Q33567644-630F9E8B-8D64-422B-8AD3-62BEECB2B06BQ33574618-8129827F-D980-47C1-BEE3-0BA1EAF61D35Q33634096-4BB08C83-FB2D-418C-9FAE-878FEB47FC71Q33787737-46A31FAC-DB8A-422C-B456-E176F2B5FFDEQ33817842-C81333A9-ABEF-4D96-8E92-0A7E01BD92E1Q33894963-F4A390CD-3770-412F-AB47-E8A56C959D5BQ33920123-C3A4AD52-631C-4C44-B0B8-E3C60CDD9598Q33986927-3FCDC776-F6E4-4AA8-99EB-0E6C57B9B002Q33993191-B5F6FC46-3D2D-4EF4-A8A7-063153C6BF2FQ34086893-5FE02A4B-CFAF-46F2-BE5B-D17B074552ABQ34135509-C4B12C4C-0420-48A0-A3B5-6B67C7BB9E41Q34154466-26EF1D9B-BFC4-4FAE-93DE-B05D43714B83Q34330950-FDEE2A13-62CA-4D38-824F-EACCDBADB1B0Q34518507-5BD47111-3A1A-4013-9AC8-2C343694A1BCQ34531240-85E54186-38AF-48FA-88F3-A17CDB98E5E2Q34536731-975A2163-2DE3-4576-AD47-C221F06F66BAQ34565911-03BD68F8-2D3C-4A2B-B9D6-359AF9F05578Q34829498-486E98D9-D88E-402F-A85E-544B628CF986Q35005946-67CFEE9B-0FD2-4B43-AD69-BF1595B897AAQ35056603-3178E997-82A0-4F96-AD68-839B0A0963DEQ35066318-20D48702-187B-41D4-AA23-206860809FD1Q35083573-14A72542-6637-4EC8-B238-D88BF0D0410FQ35118257-7013C02F-4AE0-456F-B967-C54FEEC102CCQ35120400-A4168E56-0671-49B2-9239-BB1E19F2DBB1Q35138088-8C149602-9543-40E5-B6E0-7258FF310697Q35197893-5C03DCF4-5F7C-4A7A-A042-D0B27515F91FQ35220996-819095CA-E401-4E8F-93B4-4C072AB999E4Q35557353-5DAA5B5C-2553-466F-BD58-8ADFE1109638Q35594043-ECA0AB9A-6676-4906-9E74-027341FD5A2DQ35740328-FED5EF47-0FED-4DDA-BDAC-3F84268E4AC6Q35749021-9E409360-03EC-46D6-9736-81CE2B5C069F
P2860
Basal linear deposit and large drusen are specific for early age-related maculopathy.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@en
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@nl
type
label
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@en
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@nl
prefLabel
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@en
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@nl
P1433
P1476
Basal linear deposit and large drusen are specific for early age-related maculopathy.
@en
P2093
C A Curcio
C L Millican
P304
P356
10.1001/ARCHOPHT.117.3.329
P407
P577
1999-03-01T00:00:00Z